MedPlus Health Services Limited (formerly known as MedPlus Health Services
Annexure- VIL

Notes to Restated Consol
(All amounts are it Rs in millions except as others stated)

 

 

lated Financial Information

38 Employee benefits (continued)
1. Post Employment Benefits (continued)

 

 

 

   

Particulars Torthesixmonths  Forthesixmonths  Forthe yearended  Forthe yearended Forthe year ended
period ended period ended ‘March 31, 2021 March 31,2020 March 31,2019
September 30,2021 September 30,2020
Discount rate GaSe tO 6 677% 107% aR wAoTS O77 oT 70%
Rate of return of plan assets 691% to 7.27% (0.085 691% t0 7.27% 825% 825%
Attrition rate
below 30 Years 30.00% 30.00% 30.00% 30.00% 20.00%
31-40 years 1847% 18.47% 18.47% 18.47% 20.00%
41-50 Years 13.40% 13.40% 13.40% 13.40% 20.00%
51 years and above 12.26% 12.26% 12.26% 12.26% 20.00%
Rate of compensation increase 9% to 15% 9% to 9% t0 15% 9% to 15.00%

 

“The expected future cash flows in respect of gratuity were as follows:
Particulars Torthesismonths Torthesitmonths  Forthe yearended  Fortheyearended Forthe year ended
period ended period ended March 31, 2021 March 31,2020 March 31,2019
September 30,2021 September 30,2020

 

Expected Future benefit payments

 

 

Less than a year 2085 2017 43.99 3901 17.00
Between 2-5 years 15607 14058 14426 13092 6219
More than 5 years 1335 118.19, 114 105.61 62.68

Discount rate: The discount rate is based on the prevailing market yields of Indian government securities as atthe halance sheet date forthe estimated term of the obligations.

 

Salary escalation rate: The estimates of future salary increases considered takes into account the inflation, seniority, promotion and other relevant factors.

Attrition rat
retention policy, industry factors, past experience, et.

: Represents the Company's best estimate of employee turnover in future (other than on account of retirement, death or disablement) determined considering various factors such as nature of business,

 

 

Sensitivity analysis: The sensitivity analysis presented above may not be representative ofthe actual change in the projected benefit obligation as it is unlikely thatthe change in assumptions would occur in isolation of
fone another as some of the assumptions may be correlated. Furthermore, in presenting the above sensitivity analysis, the present value of the projected benefit obligation has been calculated using the projected unit
credit method at the end of the reporting period, which is the same method as applied in calculating the projected benefit obligation as recognised in the balance sheet

BB, Defined Contribution Plan
Provident fund bene
‘The Group makes contributions, determined asa specified percentage of employee salaries, in espect of qualifying employees towards provident fund and Employee state insurance, which is defined contribution plan.
The Group has no obligations other than to make the specified contributions. The contributions are charged to the statement of profit and loss as they accrue. The amount recognised as an expense for the period /year
aggregated to Rs. 104.13millions (September 30, 2020: Rs. 72.61 millions, March 31, 2021: Rs166.58 millions, March 31, 2020: Rs156.96 millions and March 31, 2019: 132.78 millions) and is included in “contribution to
provident fund and other funds”

 

HL Other benefits
Leave compensated absences
‘The employees of the Group are entitled to compensated absences which are both accumulating and non-accumulating in nature, The expected cost of accumulating compensated absences is determined by actuarial
valuation based on the additional amount expected to be paid as a result of the unused entitlement that has accumulated at the balance sheet date, Expense on non-accumilating compensated absences is recognised in
the period in which the absences occur. The amount recognised as an expense towards leave encashment for the period /year aggregated to Rs.15.01 millions (September 30, 2020: Rs. 26.46 millions, March 31, 2021
48.24 millions, March 31, 2020: Rs 59.33 millions and March 31, 2019: Rs.22.78 millions)

39. Employee stock option plan
(a) The Company instituted MedPlus Employees Stock Option and Shares Plan 2009 (ESOP 2009). The Board of directors approved the plan on November 16, 2009. The plan is effective from November 1, 2009 which
provided for issue of 9,673 stock options (21,764 equity shares and 870,560 CPS options, including bonus issue) to eligible employees. The options vest over a period of four years or as approved by remuneration
committee and would be settled by issue of fully paid equity shares. During the six months period ended September 30, 2021 the following scheme is under operation

Pursuant to a resolution passed by the Board of Directors on February 17, 2011, the Company had formed a trust (MedPlus Employee Benefit Trust) to implement and administer ESOP 2009 and had allotted 9,673,
(21,764 equity shares and 870,560 CCPS options, including bonus issue) of Rs10 each to the Trust

‘The Company has allotted (before giving impact of bonus & split) 4110 equity shares and 5/563 shares to the trust ata premium of Rs.11,016.12 per share and Rs. 5,781 per share respectively, aggregating total securities
premium of Rs. 77.44 million.

Amount receivable from the trust for options granted aggregating to Rs.77.54 million (Face value ~ Rs 0.10 million and Premium of Rs 77.44 million) has been accounted as “Amount recoverable from Trust in kind’ and
has boen deducted from share capital and securities premium respectively as these are in the nature of own shares held, The same will be adjusted atthe time of exercise of options by the employees.

During the six months period ended September 30, 201, 8,744 options were exercised by employees which resulted in
(increase in paid up capital by Rs. 0.09 million &

(i) increase of securities premium by Rs, 67.42 million

Further, recovery of Rs. 4.72 million from ESOP trust was done on account of exercised options.

261
